The everolimus scaffold, which had mostly disappeared by 3 years, was still associated with fewer reinterventions than PTA.

Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...

Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...

The use of CGM has been growing among people without diabetes, including those with prediabetes, particularly with the ...

But in a sport where money still correlates closely with October appearances, Royals fans must ask if ownership is spending ...

Early weight loss of 2%-3% within 4 weeks is significantly linked to achieving clinically significant weight loss at 16 weeks ...

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

We assess the performance of Fallen Angels since Covid using the FTSE Time-Weighted Fallen Angel Bond Index (TWUSFA), which ...

A new lawsuit takes on computer-assisted wagering. Can the industry survive if the suit fails? Can it survive if the suit ...

Good morning, and welcome to ikeGPS First Half Financial Year 2026 Performance Update as released on the NZX and ASX this morning. [Operator Instructions] Glenn Mills, Managing Director and CEO's ...

It's been a rollercoaster ride, but investors have enjoyed a good year so far overall. So, what have been the companies ...

China yesterday set the USD/CNY fix below 7.09, its lowest level since 15 November 2024. This in turn has seen spot USD/CNY ...